Therapeutic Infliximab Levels Are Associated With Improved Clinical Outcomes in Hidradenitis Suppurativa: A Pilot Retrospective Cohort Study.

Saved in:
Bibliographic Details
Title: Therapeutic Infliximab Levels Are Associated With Improved Clinical Outcomes in Hidradenitis Suppurativa: A Pilot Retrospective Cohort Study.
Authors: Le DV; National Hospital of Dermatology and Venereology, Hanoi, Vietnam; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Tran HTT; National Hospital of Dermatology and Venereology, Hanoi, Vietnam; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Shrestha R; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Davis MDP; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Piche S; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Alavi A; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Wetter DA; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Nguyen GH; Department of Dermatology, Mayo Clinic, Rochester, MN, USA. Electronic address: nguyen.giang2@mayo.edu.
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6787
DOI:10.1016/j.jaad.2026.06.036